SCHEMBL13664952

SCHEMBL13664952

Nc1nc2c(ncn2[C@H]2CC(OC(=O)c3ccccc3)[C@@H](COC(=O)c3ccccc3)O2)c(=O)[nH]1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.55
RPS6KA3 P51812 2/20 0.55
MAPK14 Q16539 2/20 0.55
PNP P00491 2/20 0.54
HINT1 P49773 4/20 0.51
POLB P06746 2/20 0.51
RNASE1 P07998 1/20 0.48
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
P2RY2 P41231 1/20 0.47
P2RY4 P51582 1/20 0.47
P2RY6 Q15077 1/20 0.47
TAAR1 Q96RJ0 1/20 0.45
TYMP P19971 1/20 0.44
NT5E P21589 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21314724 1.00 GSK3A (0.55) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL14614379 1.00 GSK3A (0.55) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL5360855 0.90 POLB (0.62) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL16004521 0.89 POLB (0.52) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL20924430 0.89 POLB (0.52) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL22646947 0.89 POLB (0.52) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL21609615 0.89 POLB (0.52) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL16004579 0.89 POLB (0.52) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL21609616 0.89 POLB (0.52) GSK3ARPS6KA3MAPK14PNPHINT1
SCHEMBL20662556 0.88 PNP (0.45) GSK3ARPS6KA3MAPK14PNPHINT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542292-B2 Polymerizable compound, compound, and method for producing boranophosphate oligomer TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) 2023-01-03 US disclosed
US-20190270765-A1 Polymerizable Compound, Compound, and Method for Producing Boranophosphate Oligomer TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) 2019-09-05 US disclosed
US-20090270604-A1 METHOD FOR THE PREPARATION OF 2-HALO-2'-DEOXYADENOSINE COMPOUNDS FROM 2'-DEOXYGUANOSINE BRIGHAM YOUNG UNIVERSITY 2009-10-29 US disclosed
US-7572909-B2 Method for the preparation of 2-halo-2′-deoxyadenosine compounds from 2′-deoxyguanosine BRIGHAM YOUNG UNIVERSITY (US) 2009-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190270765-A1 Polymerizable Compound, Compound, and Method for Producing Boranophosphate Oligomer OXER1, RPA3, POF1B GSK3A 3214/4885RPS6KA3 3526/4885MAPK14 2565/4885
US-20090270604-A1 METHOD FOR THE PREPARATION OF 2-HALO-2'-DEOXYADENOSINE COMPOUNDS FROM 2'-DEOXYGUANOSINE DCTD, CDA, UNG GSK3A 2597/4885RPS6KA3 2889/4885MAPK14 4662/4885
US-11542292-B2 Polymerizable compound, compound, and method for producing boranophosphate oligomer OXER1, RPA3, POF1B GSK3A 3214/4885RPS6KA3 3526/4885MAPK14 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.